Raloxifene

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on April 18, 2025.

Return to the list of Patented Medicine Litigation page.





Raloxifene

EVISTA – Eli Lilly Canada Inc. (NOC Search)

Patents:

  • 2101356: TEVA, NOVOPHARM, APOTEX, APOTEX, NOVOPHARM
  • 2143263: NOVOPHARM
  • 2158399: APOTEX, NOVOPHARM
  • 2158400: APOTEX, TEVA, NOVOPHARM, APOTEX
  • 2250191: TEVA, NOVOPHARM, TEVA, NOVOPHARM, APOTEX, APOTEX, NOVOPHARM

APOTEX

APOTEX, NOVOPHARM, TEVA

NOVOPHARM

TEVA, NOVOPHARM

TEVA, NOVOPHARM, APOTEX


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property